Heteronanoparticles (H-NPs) consisting of conjugates characterized by a squalene tail linked to doxorubicin and ecdysteroid derivatives are presented. Biological evaluation on A2780ADR cell line confirms not only the maintenance of the activity of the parental drug but also the ability to overcome cancer resistance. The in vitro cell uptake was demonstrated, and the involvement of an endosomal-mediated pathway was suggested.
Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates to Overcome Cancer Resistance / G. Fumagalli, G. Giorgi, M. Vágvölgyi, E. Colombo, M. Christodoulou, V. Collico, D. Prosperi, F. Dosio, A. Hunyadi, M. Montopoli, M. Hyeraci, A. Silvani, G. Lesma, L.D. Via, D. Passarella. - In: ACS MEDICINAL CHEMISTRY LETTERS. - ISSN 1948-5875. - 9:5(2018 Apr 17), pp. 468-471. [10.1021/acsmedchemlett.8b00078]
Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates to Overcome Cancer Resistance
G. Fumagalli;E. Colombo;M. Christodoulou;A. Silvani;G. Lesma;D. Passarella
Ultimo
2018
Abstract
Heteronanoparticles (H-NPs) consisting of conjugates characterized by a squalene tail linked to doxorubicin and ecdysteroid derivatives are presented. Biological evaluation on A2780ADR cell line confirms not only the maintenance of the activity of the parental drug but also the ability to overcome cancer resistance. The in vitro cell uptake was demonstrated, and the involvement of an endosomal-mediated pathway was suggested.File | Dimensione | Formato | |
---|---|---|---|
ACS Med. Chem. Lett. 2018, 9, 468−471.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
2.38 MB
Formato
Adobe PDF
|
2.38 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Ecdy-Doxo Passarella ACSMedChemLett rev.docx
Open Access dal 17/04/2019
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
11.27 MB
Formato
Microsoft Word XML
|
11.27 MB | Microsoft Word XML | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.